1,111
Views
13
CrossRef citations to date
0
Altmetric
Retracted Article

RETRACTED ARTICLE: The circular RNA ZNF292 alleviates OGD-induced injury in H9c2 cells via targeting BNIP3

, & ORCID Icon
Pages 3365-3377 | Received 15 Aug 2019, Accepted 29 Sep 2019, Published online: 13 Oct 2019
 

Statement of Retraction

We, the Editors and Publisher of the journal Cell Cycle, have retracted the following article:

Qi Ren, Hu Li and Xiaowen Wang. The circular RNA ZNF292 alleviates OGD-induced injury in H9c2 cells via targeting BNIP3. Cell Cycle. 2019;18(23):3365-3377. doi: 10.1080/15384101.2019.1676585

Since publication, the authors have raised significant concerns about the reliability of the data presented in the article. As the Editor and Publisher also have concerns about the integrity of the reported results, all parties have agreed to retract the article to ensure correction of the scholarly record.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

View retraction statement:
Statement of Retraction: The circular RNA ZNF292 alleviates OGD-induced injury in H9c2 cells via targeting BNIP3
View addendum:
Expression of Concern: The circular RNA ZNF292 alleviates OGD-induced injury in H9c2 cells via targeting BNIP3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.